The latest update is out from Amedisys ( (AMED) ).

Reports Q3 revenue $587.7M, consensus $588.05M. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers ...

Amedisys, Inc. is being acquired by UnitedHealth for $3.3 billion, pending DOJ approval, with the stock currently trading below the offer price. The DOJ is scrutinizing the merger due to concerns ...

Leaders at UnitedHealth Group and Amedisys are set to meet with the Department of Justice (DOJ) this week in hopes of avoiding a potential attempt to block their $3.3 billion merger deal ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers in a last-ditch effort to persuade the agency not to challenge their ...

Get prepared with the key expectations. Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare have been highlighted in this Industry Outlook article. Dependence on telehealth and AI ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Amedisys (AMED).

The company’s ROE of 17.8% compares favorably with the industry’s 8.2%. Amedisys: Amedisys, a well-known provider of home health, hospice and high-acuity care, reported its second-quarter 2024 ...